PD-L1 PET Imaging During Neoadjuvant (Chemo)Radiotherapy in Esophageal and Rectal Cancer

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

December 1, 2025

Study Completion Date

June 1, 2026

Conditions
Rectal Cancer StageOesophageal Cancer
Interventions
RADIATION

CRT

50 Gy in 2 Gy fractions over 25 working days + capecitabine 1650 mg/m2/d PO

RADIATION

SCPRT

25 Gy in 5 Gy fractions over 5 working days

RADIATION

CROSS Protocol

41.4 Gy in 1.8 Gy fractions over 23 working days + carboplatin AUC of 2 mg/ml/min + paclitaxel 50 mg/m2 IV Q1W

DIAGNOSTIC_TEST

PD-L1 PET

10 mg atezolizumab IV followed by 37 MBq 89Zr-atezolizumab IV. PET imaging will be done before neoadjuvant CRT/SCPRT (day 0) and between day 10-14 during CRT/SCPRT.

Trial Locations (1)

1090

RECRUITING

Medical University of Vienna, Vienna

All Listed Sponsors
lead

Johannes Laengle, MD, PhD

OTHER